ConductScience.org, home

Paper18802412

Recommendations for identification and public health management of persons with chronic hepatitis B virus infection.

Weinbaum CM and 8 others. MMWR Recomm Rep, 2008. Cited by 516 papers, by iCite.

Cite this record

ConductScience Library. Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. Papers, record 18802412. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/18802412

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Recommendations for identification and public health management of persons with chronic hepatitis B virus infection.
PubMed
Journal
MMWR Recomm Rep
PubMed
Year
2008
PubMed
Publication types
Journal Article, Practice Guideline
PubMed
Citations, by iCite
516
iCite
Relative citation ratio, by iCite
15.7
iCite
Revised in PubMed
2025-06-13
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Weinbaum CMCindy M
2Williams IIan
3Mast EEEric E
4Wang SASusan A
5Finelli LLyn
6Wasley AAnnemarie
7Neitzel SMStephanie M
8Ward JWJohn W
9Centers for Disease Control and Prevention (CDC)Group

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Hepatitis B Surface AntigensMajor topic
Hepatitis B, ChronicMajor topic
Mass ScreeningMajor topic
Adolescent
Adult
Centers for Disease Control and Prevention, U.S.
Child
Contact Tracing
DNA, Viral
Female
Hepatitis B Vaccines
Hepatitis B virus
Humans
Male
Population Surveillance
Prevalence
Public Health
Risk Factors
United States

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT03471624Treatment Outcomes in Chronic Hepatitis B Patients on Sequential Therapy With Tenofovir Alafenamide (TAF)Background

Source ClinicalTrials.gov

Download CSV of trials

Cited by327

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 516 citations.

PMIDTitleJournalYearIn PapersSource
42620045Divergent hepatitis B neutralizing antibody trajectories after spontaneous control in people with and without HIV.Res Sq2026https://conductscience.org/library/papers/42620045PubMed
42240959Hepatitis B Screening, Antiviral Prophylaxis, and Reactivation Risk in Rituximab-Treated Patients: A 17-Year Population-Based Cohort Study Highlighting Current Practices and Gaps.Dig Dis Sci2026https://conductscience.org/library/papers/42240959PubMed
42210247
Serological epidemiology of hepatitis B virus and vaccine-induced immune dynamics in 58,169 children in Wuhan, China (2019-2025): a cross-sectional analysis of waning immunity and adolescent susceptibility.
Virol J2026https://conductscience.org/library/papers/42210247PubMed
41351332Chronic Hepatitis B Virus Infection Acquired Under Cytostatic Treatment in Childhood - Clinical, Virological and Immunological Long-Term Follow-Up.J Viral Hepat2026https://conductscience.org/library/papers/41351332PubMed
41341015Knowledge, Attitudes, and Practices Regarding Hepatitis B and Liver Cancer Among Liver Cancer Patients and Their Families in China.Cancer Manag Res2025https://conductscience.org/library/papers/41341015PubMed
41335575Tenofovir alafenamide for prevention of HBV reactivation in HBsAg-negative, anti-HBc-positive patients undergoing rituximab-based chemotherapy: A multicenter randomized controlled trial.Hepatol Commun2025https://conductscience.org/library/papers/41335575PubMed
41003568Prevalence and Screening Rates of Hepatitis B and Hepatitis C Infections in Adult Patients with Solitary Organ Tumors.Trop Med Infect Dis2025https://conductscience.org/library/papers/41003568PubMed
40906889Identifying determinants of viral hepatitis and liver cancer care in Michigan Asian American communities through multilevel engagement.Hepatol Commun2025https://conductscience.org/library/papers/40906889PubMed
40736453Racial Disparities in Comorbidity Patterns of Early-Onset Liver Cancer: A Machine Learning Analysis.Cancer Control2025https://conductscience.org/library/papers/40736453PubMed
40260164Prevention practices of hepatitis B virus and its associated factors among barbers in East Gojjam Zone, Northwest Ethiopia.Front Public Health2025https://conductscience.org/library/papers/40260164PubMed
40048081Chronic Viral Hepatitis Screening Inequities Across Florida Federally Qualified Health Centers.J Racial Ethn Health Disparities2026https://conductscience.org/library/papers/40048081PubMed
39129946A Review of the Systemic Manifestations of Hepatitis B Virus Infection, Hepatitis D Virus, Hepatocellular Carcinoma, and Emerging Therapies.Gastro Hep Adv2024https://conductscience.org/library/papers/39129946PubMed
39129942The Epidemiology, Transmission, Genotypes, Replication, Serologic and Nucleic Acid Testing, Immunotolerance, and Reactivation of Hepatitis B Virus.Gastro Hep Adv2024https://conductscience.org/library/papers/39129942PubMed
39078109Self-reported hepatitis B testing among noninstitutionalized adults in the United States before the implementation of universal screening, 2013-2017: A nationwide population-based study.J Viral Hepat2024https://conductscience.org/library/papers/39078109PubMed
39046551Impact of universal hepatitis B virus (HBV) screening using chemotherapy orders on the HBV reactivation in cancer patients.Support Care Cancer2024https://conductscience.org/library/papers/39046551PubMed
39037155Modelling the potential impact of global hepatitis B vaccination on the burden of chronic hepatitis B in the United States.J Viral Hepat2024https://conductscience.org/library/papers/39037155PubMed
38839381Development of a risk prediction score for screening for HBV, HCV and HIV among migrants in France: results from a multicentre observational study (STRADA study).BMJ Open2024https://conductscience.org/library/papers/38839381PubMed
38353882Consensus Guidelines: Best Practices for the Prevention, Detection and Management of Hepatitis B Virus Reactivation in Clinical Trials with Immunosuppressive/Immunomodulatory Therapy.Drug Saf2024https://conductscience.org/library/papers/38353882PubMed
38200947Disparities in Healthcare and HBV Vaccination by Smoking Status: Findings from the National Health and Nutrition Examination Survey (NHANES) 2017-2018.Healthcare (Basel)2023https://conductscience.org/library/papers/38200947PubMed
37554925Enhancing interventions for prevention of mother-to-child- transmission of hepatitis B virus.JHEP Rep2023https://conductscience.org/library/papers/37554925PubMed

See all 327 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/18802412

GET https://conductscience.org/api/papers/v1/18802412/cited_by?page=2